妇科肿瘤学工作组：早期乳腺癌患者的诊断和治疗建议：2023年更新
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.
作者信息
Park-Simon Tjoung-Won, Müller Volkmar, Jackisch Christian, Albert Ute-Susann, Banys-Paluchowski Maggie, Bauerfeind Ingo, Blohmer Jens-Uwe, Budach Wilfried, Dall Peter, Ditsch Nina, Fallenberg Eva Maria, Fasching Peter A, Fehm Tanja, Friedrich Michael, Gerber Bernd, Gluz Oleg, Harbeck Nadia, Hartkopf Andreas D, Heil Joerg, Huober Jens, Kolberg-Liedtke Cornelia, Kreipe Hans H, Krug David, Kühn Thorsten, Kümmel Sherko, Loibl Sibylle, Lüftner Diana, Lux Michael Patrick, Maass Nicolai, Mundhenke Christoph, Reimer Toralf, Rhiem Kerstin, Rody Achim, Schmidt Marcus, Schneeweiss Andreas, Schütz Florian, Sinn Hans Peter, Solbach Christine, Solomayer Erich-Franz, Stickeler Elmar, Thomssen Christoph, Untch Michael, Witzel Isabell, Wöckel Achim, Wuerstlein Rachel, Janni Wolfgang, Thill Marc
机构信息
Klinik für Frauenheilkunde und Geburtshilfe, Medizinische Hochschule Hannover, Hannover, Germany.
Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
出版信息
Breast Care (Basel). 2023 Aug;18(4):289-305. doi: 10.1159/000531578. Epub 2023 Jun 16.
Abstract
BACKGROUND
Each year the interdisciplinary Arbeitsgemeinschaft Gynäkologische Onkologie (AGO), German Gynecological Oncology Group Breast Committee on Diagnosis and Treatment of Breast Cancer provides updated state-of-the-art recommendations for early and metastatic breast cancer.
SUMMARY
The updated evidence-based treatment recommendation for early and metastatic breast cancer has been released in March 2023.
KEY MESSAGES
This paper concisely captures the updated recommendations for early breast cancer chapter by chapter.
摘要
背景
每年，跨学科的德国妇科肿瘤学工作组（AGO）的乳腺癌诊断与治疗乳腺委员会都会为早期和转移性乳腺癌提供最新的前沿治疗建议。
总结
关于早期和转移性乳腺癌的最新循证治疗建议已于2023年3月发布。
关键信息
本文逐章简要总结了早期乳腺癌的最新建议。
相似文献
1
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.妇科肿瘤学工作组：早期乳腺癌患者的诊断和治疗建议：2023年更新
Breast Care (Basel). 2023 Aug;18(4):289-305. doi: 10.1159/000531578. Epub 2023 Jun 16.
2
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.妇科肿瘤协作组《早期乳腺癌患者诊断与治疗建议：2024年更新》
Breast Care (Basel). 2024 Jun;19(3):165-182. doi: 10.1159/000538596. Epub 2024 Apr 18.
3
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.AGO早期乳腺癌患者诊断与治疗建议：2022年更新版
Breast Care (Basel). 2022 Aug;17(4):403-420. doi: 10.1159/000524879. Epub 2022 May 5.
4
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.妇科肿瘤学工作组：局部晚期和转移性乳腺癌患者的诊断和治疗建议：2024年更新
Breast Care (Basel). 2024 Jun;19(3):183-191. doi: 10.1159/000538753. Epub 2024 Apr 10.
5
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.AGO关于局部晚期和转移性乳腺癌患者诊断与治疗的建议：2022年更新版
Breast Care (Basel). 2022 Aug;17(4):421-429. doi: 10.1159/000524789. Epub 2022 May 2.
6
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019.AGO关于局部晚期和转移性乳腺癌患者诊断与治疗的建议：2019年更新版
Breast Care (Basel). 2019 Aug;14(4):247-255. doi: 10.1159/000500999. Epub 2019 Jul 30.
7
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023.AGO关于局部晚期和转移性乳腺癌患者诊断与治疗的建议：2023年更新版
Breast Care (Basel). 2023 Aug;18(4):306-315. doi: 10.1159/000531579. Epub 2023 Jun 16.
8
Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations.早期乳腺癌的治疗：在当前德国治疗建议背景下召开的第18届圣加仑国际乳腺癌共识会议
Geburtshilfe Frauenheilkd. 2023 Sep 12;83(9):1102-1116. doi: 10.1055/a-2121-2495. eCollection 2023 Sep.
9
Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference.早期乳腺癌患者的治疗：证据、争议、共识：德国专家对第17届国际圣加仑共识会议的看法
Geburtshilfe Frauenheilkd. 2021 Jun;81(6):637-653. doi: 10.1055/a-1483-2782. Epub 2021 May 19.
10
German Recommendations for Diagnosis and Treatment of Breast Cancer 2008. What is New from the Breast Commission of the German Gynaecological Oncology Working Group (AGO)?《2008年德国乳腺癌诊断与治疗建议》。德国妇科肿瘤学工作组（AGO）乳腺委员会有哪些新内容？
Breast Care (Basel). 2008;3(2):93-99. doi: 10.1159/000127441. Epub 2008 May 15.
引用本文的文献
1
Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer.瑞博西尼联合非甾体芳香化酶抑制剂与卵巢功能抑制对比他莫昔芬用于绝经前早期乳腺癌女性的间接治疗比较
Geburtshilfe Frauenheilkd. 2025 Apr 4;85(6):599-610. doi: 10.1055/a-2561-6640. eCollection 2025 Jun.
2
Evolution of localization methods for non-palpable breast lesions: a literature review from a translational medicine perspective.不可触及乳腺病变定位方法的演变：从转化医学角度的文献综述
Transl Breast Cancer Res. 2024 Apr 15;5:12. doi: 10.21037/tbcr-23-49. eCollection 2024.
3
Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020.使用2010年至2020年德国真实世界理赔数据的乳腺癌疾病模型的实施与评估
Cancers (Basel). 2024 Apr 13;16(8):1490. doi: 10.3390/cancers16081490.
4
HER2-Positive Early Breast Cancer: Time for Ultimate De-Escalation?人表皮生长因子受体2阳性早期乳腺癌：是时候进行最终的降阶梯治疗了吗？
Cancers (Basel). 2024 Mar 11;16(6):1121. doi: 10.3390/cancers16061121.
5
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective.第 18 届圣加仑国际乳腺癌共识会议放射治疗声明——德国专家观点。
Strahlenther Onkol. 2024 Jun;200(6):461-467. doi: 10.1007/s00066-024-02209-7. Epub 2024 Feb 23.
6
Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal Inhibition.内分泌治疗：从卵巢切除到个体化治疗与信号抑制
Breast Care (Basel). 2023 Dec;18(6):440-447. doi: 10.1159/000534154. Epub 2023 Sep 19.
7
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers.NATALEE 研究的临床相关性：NATALEE 标准在来自两个德国大型乳腺癌中心的真实世界队列中的应用。
Int J Mol Sci. 2023 Nov 15;24(22):16366. doi: 10.3390/ijms242216366.
8
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management.液体活检的多样性及其在乳腺癌管理中的潜力。
Cancers (Basel). 2023 Nov 17;15(22):5463. doi: 10.3390/cancers15225463.
本文引用的文献
1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.乳腺癌后中断内分泌治疗尝试妊娠。
N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856.
2
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance).多灶性同侧乳腺癌患者保乳治疗后的局部复发：ACOSOG Z11102（Alliance）研究结果。
J Clin Oncol. 2023 Jun 10;41(17):3184-3193. doi: 10.1200/JCO.22.02553. Epub 2023 Mar 28.
3
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).不可触及乳腺病变的定位技术：现状、知识空白及MELODY研究（EUBREAST-4/iBRA-NET，NCT 05559411）的理论依据
Cancers (Basel). 2023 Feb 12;15(4):1173. doi: 10.3390/cancers15041173.
4
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.绝经前乳腺癌患者的辅助依西美坦加卵巢抑制：TEXT 和 SOFT 联合试验的长期随访。
J Clin Oncol. 2023 Mar 1;41(7):1376-1382. doi: 10.1200/JCO.22.01064. Epub 2022 Dec 15.
5
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.阿贝西利联合内分泌治疗激素受体阳性、HER2 阴性、淋巴结阳性、高危早期乳腺癌（monarchE）：一项随机、开放标签、III 期临床试验的预先计划的中期分析结果。
Lancet Oncol. 2023 Jan;24(1):77-90. doi: 10.1016/S1470-2045(22)00694-5. Epub 2022 Dec 6.
6
Oral Contraceptive Use and Assessment of Breast Cancer Risk among Premenopausal Women via Molecular Characteristics: Systematic Review with Meta-Analysis.口服避孕药的使用与基于分子特征的绝经前妇女乳腺癌风险评估：系统评价与荟萃分析。
Int J Environ Res Public Health. 2022 Nov 21;19(22):15363. doi: 10.3390/ijerph192215363.
7
Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis.胸肌前与胸肌下假体置入乳房重建的系统评价和荟萃分析。
Ann Surg Oncol. 2023 Jan;30(1):126-136. doi: 10.1245/s10434-022-12567-0. Epub 2022 Oct 16.
8
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.OlympiA 三期临床试验中奥拉帕利辅助治疗用于携带 BRCA1/2 种系致病性变异的高危早期乳腺癌患者的总生存情况。
Ann Oncol. 2022 Dec;33(12):1250-1268. doi: 10.1016/j.annonc.2022.09.159. Epub 2022 Oct 10.
9
Breast Density and Breast Cancer Screening with Digital Breast Tomosynthesis: A TOSYMA Trial Subanalysis.乳腺密度与数字乳腺断层合成摄影在乳腺癌筛查中的应用：TOSYMA 试验的亚组分析。
Radiology. 2023 Feb;306(2):e221006. doi: 10.1148/radiol.221006. Epub 2022 Oct 4.
10
Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding.母乳喂养可降低乳腺癌风险：呼吁在母乳喂养率低的高收入国家采取行动。
Cancer Med. 2023 Feb;12(4):4616-4625. doi: 10.1002/cam4.5288. Epub 2022 Sep 26.
Zotero 插件